http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101272470-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101272470-B1
titleOfInvention A pharmaceutical composition having both fast-acting and long-lasting properties, including leprotropizin
abstract The present invention relates to a pharmaceutical composition having both fast-acting and long-lived, including leprotropypizin, and more particularly, by having a fast-release portion and a slow-release portion exhibiting independent release characteristics, it is possible to simultaneously increase fast drug efficacy and ease of taking. In addition, the dissolution stability is also improved, and relates to a pharmaceutical composition having both fast-acting and long-term sustainability, including leprotropypizin can expect improved treatment effect.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101811700-B1
priorityDate 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110113413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018934-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387

Total number of triples: 52.